AXA1125 – A New Mitochondrial Enhancer Is Being Trialed in Long COVID
I have a feeling that interesting treatment trials for long COVID may become a regular blog topic on Health Rising. That would be a nice change. Treatment trials have been chronic fatigue syndrome’s Achilles heel. Except for cognitive behavioral therapy (CBT)...
Inspiritol – A New Investigational Drug Announced for ME/CFS and Long COVID
A new drug called Inspiritol, has begun the process to too clinical trials in long COVID and chronic fatigue syndrome.
20-Year Study Finds High Rates of Metabolic Dysfunctions in Exercise Intolerance: Promotes Metabolic Treatments
A 20 year study of mostly fibromyalgia patients findings exercise intolerance is almost always associated with a metabolic dysfunction which can be improved with supplements or diet.
Oxaloacetate: the Best Mitochondrial Supplement for ME/CFS (and Long COVID?)
Oxaloacetate reduces fatigue significantly in 80% of people with chronic fatigue syndrome in an early study. More study is needed.
IACFS/ME Conference 2021 Pt. III – the Exercise Studies: Long COVID Moves Closer to ME/CFS, Metabolomic Weirdness, Two Symptoms to Rule Them All?
Exercise studies at the 2021 IACFS/ME conference suggest that long COVID is similar to ME/CFS, that exercise significantly alters ME/CFS patients metabolism and immune functioning, and that two symptoms may be able to identify post-exertional malaise state that exercise induces.Lives Interrupted Latest Story
Don
Langham, Canada
Former occupation: Heavy duty journeyman Mechanic
CA $149,607
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
